squamous cell carcinoma

Representative image: A clinician uses a handheld skin assessment device, reflecting DermaSensor’s CE Mark and the growing role of AI-assisted skin cancer triage in European primary care.

Pharma & Biotech

Could DermaSensor’s NHS study turn AI skin cancer tools into primary care infrastructure?

by Pallavi Madhiraju
June 11, 2026
0 Comments

Find out how DermaSensor’s CE Mark and NHS study could reshape AI-assisted skin cancer assessment across European primary care.

Read More

Pharma & Biotech

Can CRISPR editing of NRF2 reverse resistance in head and neck squamous cell carcinoma?

by Pallavi Madhiraju
January 24, 2026
0 Comments

CorriXR’s new data show CRISPR-based NRF2 disruption restores chemo response in squamous tumors. Find out what this could mean for HNSCC treatment.

Read More